“Don’t downplay what you’re seeing,” said Danielle Ripley-Burgess ...

When a colon tumor grows large enough to completely block the bowel, surgeons have traditionally faced an unenviable choice: ...

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...

A pattern-based p53 immunohistochemistry test identified patients with colorectal liver metastases at nearly four times the ...

Tecentriq or Tecentriq Hybreza may be used with the medicines paclitaxel protein-bound and carboplatin as your first treatment when your lung cancer: has spread or grown, and is a type called ...

I stopped the colorectal cancer chemotherapy XELOX after 4 cycles because the side effects were too hard — at the end of that year, my tumor markers skyrocketedIn my previous article, I wrote about my ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...

This marks a significant new indication for cadonilimab beyond gastric, lung, and cervical cancers, and represents the 13th Phase III/registrational study of the therapy conducted globally.

The approach only works for a specific genetic subtype of bowel cancer, and the researchers now say they can predict who it ...

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia showed early-onset ...